Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Buy
+4,806
New +$442K ﹤0.01% 798
2026
Q1
Sell
-7,575
Closed -$492K 883
2025
Q4
$492K Buy
7,575
+4,517
+148% +$410K ﹤0.01% 771
2025
Q3
$455K Sell
3,058
-130
-4% -$19.1K ﹤0.01% 821
2025
Q2
$463K Sell
3,188
-25
-0.8% -$3.62K ﹤0.01% 802
2025
Q1
$406K Buy
+3,213
New +$406K ﹤0.01% 813
2023
Q4
Sell
-13,796
Closed -$621K 995
2023
Q3
$621K Sell
13,796
-20,607
-60% -$838K ﹤0.01% 748
2023
Q2
$1.28M Sell
34,403
-867
-2% -$34.7K 0.01% 793
2023
Q1
$1.38M Buy
+35,270
New +$1.38M 0.01% 809
2022
Q4
Sell
-40,611
Closed -$1.71M 1014
2022
Q3
$1.71M Buy
40,611
+22,637
+126% +$912K 0.01% 728
2022
Q2
$733K Buy
+17,974
New +$666K ﹤0.01% 995

Other funds holding LRN

Aviva's LRN Position: Q2 2026 in Review

Aviva opened a new position in Stride (LRN) in Q2 2026: 4,806 shares worth $414K. The stake represents ﹤0.01% of the portfolio and ranks #798 among its holdings. This is a return to the name: Aviva previously reported a position in LRN as recently as Q4 2025.

Aviva first reported a position in LRN in Q2 2022 and has held it in 10 quarters since. The position peaked at $1.71M in Q3 2022. 413 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

  • Aviva held 4,806 shares of Stride worth $414K as of Q2 2026.
  • Stride was a new Aviva position in Q2 2026.
  • Stride made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #798 holding.
  • Aviva first reported a position in Stride in Q2 2022 and has held it in 10 quarters since.
  • Aviva's Stride position peaked at $1.71M in Q3 2022.
  • 413 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.